Revolution Medicines, Inc.

RVMD

$204.97

Name : Revolution Medicines, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $43,932,536,832.00

EPSttm : -8.88

Revolution Medicines, Inc.

$204.97

2.56%

$5.11

RVMD — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.01

Margin Of Safety %

Put/Call OI Ratio

0.7

EPS Next Q Diff

0.29

EPS Last/This Y

-3.74

EPS This/Next Y

3.68

Price

205.05

Target Price

253.92

Analyst Recom

1.09

Performance Q

12.57

Upside

-250.4%

Beta

1.4

Ticker: RVMD

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	RVMD	207.98	0.52	0.50	67919
2026-08-31	RVMD	205.72	0.52	0.13	68868
2026-09-02	RVMD	209.23	0.53	0.33	68719
2026-09-03	RVMD	210.87	0.54	2.57	68841
2026-09-04	RVMD	210.14	0.55	0.54	69728
2026-09-08	RVMD	207.05	0.56	0.55	70236
2026-09-09	RVMD	207.66	0.56	0.47	70213
2026-09-10	RVMD	203.27	0.56	0.45	70378
2026-09-11	RVMD	203.88	0.56	0.08	70457
2026-09-14	RVMD	205.06	0.63	0.31	66272
2026-09-15	RVMD	205.2	0.63	1.08	66558
2026-09-16	RVMD	196.1	0.63	0.34	66581
2026-09-17	RVMD	196.94	0.61	0.68	67862
2026-09-18	RVMD	190.96	0.61	0.44	67927
2026-09-21	RVMD	192.76	0.71	0.19	44502
2026-09-22	RVMD	193.26	0.71	1.62	44871
2026-09-23	RVMD	190.73	0.71	0.35	45503
2026-09-24	RVMD	200.22	0.71	0.13	45650
2026-09-25	RVMD	205.02	0.70	0.41	46464
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	RVMD	208.34	-52.5	-	-9.66
2026-08-31	RVMD	205.66	-52.4	-	-9.76
2026-09-01	RVMD	209.87	-51.7	-	-9.78
2026-09-02	RVMD	209.20	-51.7	-	-9.78
2026-09-03	RVMD	210.91	-51.7	-	-9.78
2026-09-04	RVMD	210.10	-51.7	-	-9.78
2026-09-08	RVMD	207.14	-51.4	-	-9.73
2026-09-09	RVMD	207.73	-51.4	-	-9.73
2026-09-10	RVMD	203.43	-51.4	-	-9.73
2026-09-11	RVMD	203.82	-51.4	-	-9.73
2026-09-14	RVMD	205.02	-51.4	-	-9.73
2026-09-15	RVMD	205.06	-51.0	-	-9.73
2026-09-16	RVMD	205.06	-51.0	-	-9.73
2026-09-17	RVMD	196.80	-51.0	-	-9.73
2026-09-18	RVMD	190.91	-51.0	-	-9.73
2026-09-21	RVMD	192.71	-51.0	-	-9.73
2026-09-22	RVMD	193.01	-51.0	-	-9.73
2026-09-23	RVMD	190.78	-51.0	-	-9.73
2026-09-24	RVMD	199.75	-51.0	-	-9.73
2026-09-25	RVMD	205.05	-49.1	-	-9.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	RVMD	-2.38	6.83	5.04
2026-08-31	RVMD	-2.38	6.90	5.04
2026-09-01	RVMD	-2.38	6.90	5.04
2026-09-02	RVMD	-2.38	6.90	5.04
2026-09-03	RVMD	-2.63	6.90	5.04
2026-09-04	RVMD	-2.47	6.90	5.04
2026-09-08	RVMD	-2.47	6.41	5.04
2026-09-09	RVMD	-2.48	6.41	5.04
2026-09-10	RVMD	-2.48	6.41	5.04
2026-09-11	RVMD	-2.55	6.41	5.04
2026-09-14	RVMD	-2.55	6.42	5.04
2026-09-15	RVMD	-2.65	6.42	5.04
2026-09-16	RVMD	-3.05	6.42	5.04
2026-09-17	RVMD	-3.05	6.42	5.04
2026-09-18	RVMD	-3.05	6.42	5.04
2026-09-21	RVMD	-3.07	6.44	5.04
2026-09-23	RVMD	-3.07	6.44	5.04
2026-09-24	RVMD	-3.07	6.44	5.04
2026-09-25	RVMD	-3.12	6.44	5.01
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-2.34

Avg. EPS Est. Current Quarter

-2.4

Avg. EPS Est. Next Quarter

-2.05

Insider Transactions

-3.12

Institutional Transactions

6.44

Beta

1.4

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

149

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

8.6

Max Drawdown 5-Year %

-56.9

Target Price

253.92

P/E

Forward P/E

PEG

P/S

P/B

16.85

P/Free Cash Flow

EPS

-8.81

Average EPS Est. Cur. Y

-9.69

EPS Next Y. (Est.)

-6.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.15

Return on Equity vs Sector %

-94.1

Return on Equity vs Industry %

-74.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ RVMD Healthcare

$204.97

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

13/25

Volume

4/15

Valuation

6/20

TP/AR

5/10

Options

5/10

RSI

54.5

Range 1M

51.9%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

10/30

Estimates

6/20

Inst/Vol

10/15

Options

6/10

EPS Yr

-62.7%

EPS NY

37.8%

52W%

90.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +23.9% upside

Quality

2/30

Valuation

6/30

Growth

8/25

Stability

7/10

LT Trend

3/5

Upside

+23.9%

Quality

RVMD — P/E HistoricalBiotechnology

Revolution Medicines, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 883

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

RVMD

Latest News

—

Caricamento notizie per RVMD…

stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today

news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance

stock history RVMD – Revolution Medicines, Inc. invest stock market

stock prices RVMD premarket after hours

ticker RVMD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RVMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y